Believe me, if I knew ANYTHING about the ebola trials, I would share; but, unfortunately, I do not.
You are correct: Vical could have/should have addressed this; but, perhaps it was a conscious decision not to. Since they did not mention it, perhaps we can infer that there is nothing going on. Had they mentioned it (and said something along the lines that they are not "interested" in pursuing the ebola issue), perhaps the stock price would have been adversely affected, I don't know (speculation). But if they ARE still pursuing the ebola effort, then saying something about it during the CC would have been an absolutely perfect opportunity. My feeling is that by remaining silent on it means that they are not dedicating any energy in this effort.
All IMO. GL to you and all.
P.S. - Nice to see short interest declining (as of 15 October 2014):
http://www.nasdaq.com/symbol/vicl/short-interest
Article I, Section. 10. No State shall...make any Thing but gold and silver Coin a Tender in Payment of Debts;...or Law impairing the Obligation of Contracts [ask GM bondholders!].
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM